Core Insights - OpenEvidence, an AI search tool for doctors, has achieved a valuation of $12 billion following a recent funding round of $250 million, leading to a doubling of CEO Daniel Nadler's net worth to $7.6 billion [2][3] Company Overview - OpenEvidence has rapidly become one of the hottest AI startups in the healthcare sector, with approximately 740,000 doctors (about 45% of U.S. doctors) using the platform to quickly access millions of peer-reviewed research papers [3] - The software was utilized in around 18 million clinical inquiries last month, establishing itself as the default operating system for the medical community [3] Financial Performance - OpenEvidence is projected to surpass $100 million in annual revenue by 2025 and has already achieved profitability through advertising, with potential revenue reaching $1 billion if all advertising resources are fully utilized [3] - The company has raised a total of $700 million in funding, with recent investments led by Thrive Capital and DST Global [4] Competitive Landscape - Despite competition from tools like OpenAI's ChatGPT, Nadler is confident in OpenEvidence's unique positioning as it is specifically designed for medical professionals [4] Future Plans - The company plans to use the new funding to develop a "orchestra" of specialized models targeting specific medical fields such as oncology, radiology, and neurology, enhancing the precision of information retrieval [6]
估值120亿美元，创始人身家翻倍，这款AI工具正悄悄改变美国医疗界
3 6 Ke·2026-01-27 10:51